Buy Epizyme Stock | EPZM Stock Price & Latest News | Public
EPZM

Epizyme

$0.00 (0.00%)Today

    About EPZM

    Epizyme, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the discovery, development, and commercialization of novel epigenetic medicines for cancer and other diseases. Its product pipeline is lead by, tazemetostat which targets Non-Hodgkin Lympho...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.39
    -0.59
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.59

    Actual EPS
    Q4 2020

    Stats

    Market Cap$1,35B
    Volume25,16k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$27.82
    1 Year Low$9.90
    Open$13.59
    High$13.59
    Low$12.89

    Buy any stock with any amount of money.

    Download the App
    Download the app